Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis (NCT03553095) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis
United States92 participantsStarted 2018-07-12
Plain-language summary
This study will evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease.
Who can participate
Age range18 Years – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* At least 18 years old
* Must be a patient of the UAB Dental School
* Able to read and understand informed consent document
* Good general health as evidenced by medical history
* Minimum of 18 teeth, excluding third molars
* Having moderate to severe periodontal disease according to AAP definition (teeth ≥5 mm PD and ≥3 mm CAL)
* Having \>30 percent bleeding sites upon probing
* Patients taking depression medication with chronic periodontitis
* Patients without depression with chronic periodontitis
* Patients who have not had a dental cleaning in the past 3 months prior to procedure
* Patients scheduled for surgical procedures (i.e. gum surgery, tooth extraction, or dental implants)
Exclusion Criteria:
* Non-English speaking
* Less than 18 years old
* Smokers/tobacco users (\>10 cigarettes/day)
* Any dental condition that requires immediate treatment, such as emergency care
* Chronic use (≥3 times/week) of anti-inflammatory medications (e.g., non-steroidal anti-inflammatory drugs, steroids). Low-dose aspirin (less than 325 mg daily)
* Immunocompromised subjects
* Any medical history or any concomitant medication that might affect the assessment of the study treatment or periodontal tissues, such as uncontrolled diabetes, nifedipine, phenytoin (Dilantin), subjects with arthritis and morbidly obese (BMI ≥ 40)